ARID1A and breast cancer: Subsequently, we established stable EO771, MCF-7, and T47D clones overexpressing ARID1A respectively for further confirming that the expression level of ARID1A is crucial for eMDSCs to promote EMT of luminal A breast cancer cells (Figure 5D).